Combined Diffusion and Perfusion MR Imaging as Biomarkers of Prognosis in Immunocompetent Patients with Primary Central Nervous System Lymphoma

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma

(2011) M Deckert et al.   LEUKEMIA

Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?

(2011) Jung A. Kim et al.   LEUKEMIA & LYMPHOMA

MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas

(2011) I. S. Khayal et al.   NEURO-ONCOLOGY

Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors

(2010) Soley Bayraktar et al.   JOURNAL OF NEURO-ONCOLOGY

Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma

(2009) R.F. Barajas et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Hypoxia Helps Glioma to Fight Therapy

(2009) Verena Amberger-Murphy   CURRENT CANCER DRUG TARGETS

Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting

(2009) Gisele B. Caseiras et al.   EUROPEAN JOURNAL OF RADIOLOGY

Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study

(2008) T. Hirai et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

(2008) Carole Soussain et al.   JOURNAL OF CLINICAL ONCOLOGY